TUB Fundamental Analysis - FINANCIERE DE TUBIZE

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to TUB. TUB was compared to 55 industry peers in the Pharmaceuticals industry. While TUB has a great health rating, there are worries on its profitability. TUB does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TUB was profitable.

TUB had a negative operating cash flow in the past year.

Each year in the past 5 years TUB has been profitable.

In the past 5 years TUB always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of 4.79%, TUB perfoms like the industry average, outperforming 49.09% of the companies in the same industry.

TUB has a Return On Equity of 4.79%. This is comparable to the rest of the industry: TUB outperforms 41.82% of its industry peers.

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROIC	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

TUB has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, TUB has more shares outstanding

Compared to 1 year ago, TUB has an improved debt to assets ratio.

2.2 Solvency

TUB has an Altman-Z score of 16519.65. This indicates that TUB is financially healthy and has little risk of bankruptcy at the moment.

TUB's Altman-Z score of 16519.65 is amongst the best of the industry. TUB outperforms 100.00% of its industry peers.

There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	16519.65

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

TUB has a Current Ratio of 10.33. This indicates that TUB is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 10.33, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

A Quick Ratio of 10.33 indicates that TUB has no problem at all paying its short term obligations.

The Quick ratio of TUB (10.33) is better than 100.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	10.33
Quick Ratio	10.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.02% over the past year.

TUB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.68% yearly.

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 108.89 indicates a quite expensive valuation of TUB.

Compared to the rest of the industry, the Price/Earnings ratio of TUB indicates a slightly more expensive valuation: TUB is more expensive than 67.27% of the companies listed in the same industry.

The average S&P500 Price/Earnings ratio is at 26.92. TUB is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	108.89
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TUB has a yearly dividend return of 0.35%, which is pretty low.

TUB's Dividend Yield is comparable with the industry average which is at 1.60.

Compared to an average S&P500 Dividend Yield of 1.94, TUB's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.35%

5.2 History

The dividend of TUB is nicely growing with an annual growth rate of 7.33%!

Dividend Growth(5Y)7.33%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

TUB pays out 0.05% of its income as dividend. This is a sustainable payout ratio.

DP0.05%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FINANCIERE DE TUBIZE

EBR:TUB (1/7/2026, 7:00:00 PM)

226.5

-0.5 (-0.22%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)08-02 2025-08-02

Earnings (Next)03-21 2026-03-21

Inst Owners5.22%

Inst Owner ChangeN/A

Ins Owners33.27%

Ins Owner ChangeN/A

Market Cap10.08B

Revenue(TTM)N/A

Net Income(TTM)92.74M

Analysts76.67

Price Target235.11 (3.8%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.35%

Yearly Dividend0.97

Dividend Growth(5Y)7.33%

DP0.05%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)23.76%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	108.89
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	5.21
P/tB	5.21
EV/EBITDA	N/A

EPS(TTM)2.08

EY0.92%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.03

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS0

BVpS43.5

TBVpS43.5

PEG (NY)N/A

PEG (5Y)N/A

Graham Number45.12

Profitability

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	10.33
Quick Ratio	10.33
Altman-Z	16519.65

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-29.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-0.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-0.98%

OCF growth 3YN/A

OCF growth 5YN/A

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR.

What is the valuation status of FINANCIERE DE TUBIZE (TUB.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 2 / 10.

What are the PE and PB ratios of FINANCIERE DE TUBIZE (TUB.BR) stock?

The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 108.89 and the Price/Book (PB) ratio is 5.21.

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

What is the valuation status of FINANCIERE DE TUBIZE (TUB.BR) stock?

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

What are the PE and PB ratios of FINANCIERE DE TUBIZE (TUB.BR) stock?